Use of Low-Dose Recombinant Factor Ⅶa for Uncontrolled Perioperative Bleeding

• Main Authors: Zhi-gang Chang MD, PhD (Author), Xin Chu MD (Author), Wen Chen MD (Author), Jun-hua Hu MD (Author), Ji-wu Gong MD (Author), Da-dong Liu MD (Author), Qing He MD (Author), Zhe Feng MD (Author), Shi-rou Xiao MD (Author), Ya-lin Liu MD (Author)
• Format: Book
• Published: SAGE Publishing, 2020-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Recombinant activated factor VIIa (rFVIIa) is a prohemostatic agent initially approved for use in hemophilia patients and has also been used for a diverse range of off-label indications in the context of massive uncontrolled blood loss; however, no convincing evidence exists regarding th...